Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

NCT06770270 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Pucotenlimab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University